Nitrous oxide can look like a harmless party trick until you understand how fast it can flip into a medical emergency. We dig into whippets and laughing gas from an addiction medicine perspective, including why the high hits within seconds, why people keep reaching for “just one more,” and how the same drug can functionally mimic ketamine, benzodiazepines, and opioids in the brain. That mix helps explain both its legitimate role in minor procedures and why it can be so addictive outside the clinic. 

We walk through what clinicians and families often miss: standard urine drug screens do not detect nitrous oxide, the detection window is short even with advanced lab testing, and the clearest red flag may be a profound vitamin B12 deficiency in someone who should not have it. From there, the conversation turns to the real stakes of B12 inactivation: spinal cord degeneration, myelopathy, peripheral neuropathy, gait instability, weakness, bladder dysfunction, cognitive changes, and the uncomfortable truth that we often cannot predict whether nerve damage will be permanent. We also cover immediate dangers while using, including hypoxia and sudden unconsciousness, traumatic falls, frostbite and cold burns from direct canister inhalation, pneumothorax and pneumomediastinum, arrhythmias especially when mixed with stimulants, mental health destabilization, increased blood clot risk, and serious pregnancy risks. 

Because there is no proven medication-assisted treatment for nitrous cravings, we focus on what we can do: treat co-occurring anxiety, depression, and trauma, use CBT and group therapy, push hard on vitamin B12 replacement, and apply practical harm reduction when someone is not ready to quit. We close with a vivid patient case that shows how smoke shop access and relapse can spiral into hospitalization and disability, and how recovery is still possible with the right support. 

If you find this helpful, subscribe, share the episode with someone who needs it, and leave a review so more people can find the show.

To contact Dr. Grover: [email protected]

A benzodiazepine taper can feel like trying to land a plane in bad weather: the stakes are high, the instruments are imperfect, and speed is rarely your friend. We sit down with Dr. Rizzo to translate the ASAM benzodiazepine tapering guideline into real-world addiction medicine decisions, including what to do when a patient shows up on a very high dose of clonazepam and a sudden 50% cut has already happened.

We dig into the practical details clinicians and patients search for: how fast to reduce dose, why “5% to 10% every 2–4 weeks” is often a safer starting point, and when switching to a longer-acting benzodiazepine like diazepam helps or hurts. We also separate physical dependence from benzodiazepine use disorder so withdrawal is treated with seriousness rather than stigma, and we talk candidly about the access-to-care problem when long-term benzo patients can no longer find a prescriber.

We also cover special risks and settings: why older adults (65+) often need extra-slow tapers, why pregnancy requires careful coordination to avoid abrupt cessation, and when polysubstance use with opioids or alcohol should push care toward inpatient or residential support. Dr. Rizzo shares why phenobarbital can be useful in controlled detox settings, plus what actually improves success long term: CBT, treating underlying anxiety and insomnia with non-addictive medications, and building a plan patients can stick with.

If this helps, subscribe, share it with a colleague or family member, and leave a review so more people can find evidence-based guidance on benzodiazepine tapering and withdrawal.

ASAM Benzo Tapering Guideline: https://link.springer.com/article/10.1007/s11606-025-09499-2

To contact Dr. Grover: [email protected]

Residential treatment gets talked about like a single thing, but most people have no idea what they are walking into until they arrive. I sit down with Rachel Docekal, CEO of the Hanley Foundation in Florida, to open up the “black box” of residential addiction treatment and partial hospitalization (PHP), from how programs are structured to what patients actually do hour by hour.

We dig into what separates a quality rehab program from one that is all marketing. Rachel explains measurement based care, why repeat assessments like PHQ 9 and GAD 7 style tools matter, and how teams should adjust treatment based on data instead of vibes. We also address a hard topic: predatory rehab practices, including unethical pressure to relapse to meet ASAM criteria so insurance will pay again, and what ethical, patient centered care should look like instead.

Then we get practical. We talk length of stay, why discharge planning must start on day one, and how step down care, sober living, family involvement, and alumni support can make the difference between momentum and relapse. Rachel also walks through a real residential daily schedule including medical and psychiatric care, cohort based groups, nutrition and fitness, and why many programs restrict smartphones to improve engagement and outcomes.

If you want a clearer map for choosing a residential treatment center and building an aftercare plan that holds up in real life, press play. Subscribe, share this with someone who needs it, and leave a rating or review so more people can find the show.

To learn more about Rachel's program: https://hanleyfoundation.org/

To contact Dr. Grover: [email protected]

Someone you love keeps drinking, using, or relapsing and you can feel your body tighten the moment you walk into the room. That tension makes sense, but it can also become part of the system that keeps addiction stuck. We sit down with therapist and family coach Jeff Jones, founder of The Family Recovery Solution and author of Rethinking Addiction, to unpack what actually helps families when a loved one is in active addiction or early recovery. 

We get concrete with a classic scenario from the clinic: a middle-aged man with alcohol addiction and a spouse who loves him deeply but feels forced into constant pushing and correcting. Jeff explains why “help” can turn into pressure, how triangulation pulls doctors into the drama triangle, and how a simple 180-degree experiment plus journaling can reveal new options. We also talk boundaries as a way to create safety, calm the nervous system, and make better decisions, not as punishment or control. 

Then we widen the lens to parenting teens and the added power dynamics families face, including why authoritative parenting (firm limits with connection) tends to work best. Jeff shares a powerful reframe from mediation: separate the addiction from the essence of your loved one, so you can hold consequences while staying anchored in love. We also cover structured family meetings, the idea that families move through the stages of change too, and why recovery is about building a life worth living, not only stopping a substance. 

If this conversation helps, subscribe, share it with a family who needs it, and please leave a review so more people can find Addiction Medicine Made Easy.

To learn more about Jeff's work: https://www.thefamilyrecoverysolution.com/

To contact Dr. Grover: [email protected]

THC isn’t the same drug it was 20 years ago, and pregnancy counseling hasn’t caught up. We sit down with Dr. Nazanin Amadieh, a board-certified OBGYN who also trained in addiction medicine, to map what today’s high-potency cannabis means for conception, the placenta, fetal development, and the newborn period. If you’ve heard “it’s legal” or “it’s just a plant” as proof of safety, this conversation offers a clearer, evidence-informed way to think about marijuana during pregnancy without stigma and without hand-waving. 

We dig into the endocannabinoid system, why fetal receptors show up as early as five to six weeks, and how cannabis exposure may affect implantation, placenta formation, and early brain development. Then we get practical about the outcomes clinicians track: miscarriage risk signals, the stronger association with low birth weight or small for gestational age babies, and what NICU admission can mean for families. Because so much research is dated and modern THC concentrations can reach levels older studies never measured, we also talk openly about uncertainty and why “no proof of harm” is not the same as “safe.” 

Nausea and vomiting gets its own spotlight, including the tricky overlap between hyperemesis gravidarum and cannabinoid hyperemesis syndrome, plus the hot shower clue that can point toward CHS. We also cover breastfeeding and THC in breast milk, what parents should watch for, and why postpartum relapse to cannabis is common when anxiety and overwhelm hit after the first few months. If you care about maternal health, prenatal care, addiction medicine, or harm reduction, you’ll leave with better questions and clearer next steps. 

Subscribe, share this with someone who’s pregnant or caring for pregnant patients, and please leave a review so more people can find the show.

To contact Dr. Grover: [email protected]

Benzodiazepines can feel like flipping a switch: panic quiets, sleep finally comes, your body unclenches. But what happens when that “off switch” starts rewiring the system you rely on to stay calm in the first place? Dr Andrew Rizzo joins me to dig into the biology behind chronic benzodiazepine use and why so many clinicians now recognize benzodiazepine-induced neurological dysfunction (BIND) as a real, patient-altering condition rather than a vague catch-all for “rebound anxiety.” 

We walk through the GABA receptor in plain language, including why benzodiazepines act as positive allosteric modulators, how the brain chases homeostasis by downregulating inhibition and upregulating glutamate, and why tolerance is structural not moral. Then we connect the molecular story to the clinical reality: why abrupt benzo cessation can be life-threatening, how seizure risk emerges, what “kindling” means for repeat withdrawal attempts, and why a slow benzodiazepine taper often takes months, not weeks. 

We also spend time on what patients and families actually need during recovery: validation, steady follow-up, and a plan that treats this like a fragile neurobiological injury. If you’re a clinician, a patient, or someone supporting a loved one, you’ll leave with clearer language, sharper warning signs, and a better mental model for why symptoms like photophobia, tinnitus, tremor, and cognitive fog can persist long after the last pill. 

Subscribe, share this with someone who needs it, and leave a review with your biggest question about benzos and withdrawal.

To contact Dr. Grover: [email protected]

Fentanyl changed the playbook for starting buprenorphine, and we’re tired of watching people suffer through days of withdrawal just to “earn” their first dose. So we break down a cleaner, faster on-ramp: direct-to-inject. Think of weekly Brixadi as an automatic microdose that builds buprenorphine levels over 24 hours, cuts out guesswork, and sets up a smooth handoff to a monthly injection that actually sticks.

We start by demystifying precipitated withdrawal with simple, memorable analogies—the “100 mph to 60 mph” shift explains why heroin-era inductions no longer work when fentanyl lingers like THC. From there, we map the current options: long waits with comfort meds, meticulous sublingual microdosing, short-acting opioid bridges, and why DTI often outperforms them in the real world. You’ll hear our step-by-step protocol for week one: when to keep using, when to stop, how to layer sublingual buprenorphine, and which comfort meds reliably blunt symptoms without fogging people out.

Then we get tactical. We compare Sublocade and Brixadi in plain English—needle size, injection sites, refrigeration, and the “tail” that can protect patients who miss appointments or face custody interruptions. We explain why some teams favor weekly Brixadi for the bridge and monthly Sublocade for its long half-life, while others choose monthly Brixadi for logistics and patient comfort. We also clear up a big myth: yes, you can supplement injectables with sublingual buprenorphine when needed.

What matters most is the outcome. DTI compresses complexity into a single, supported action and replaces fear with momentum. Patients report fewer false starts, less chaos, and a quicker path to cravings control and stability. For clinicians and outreach teams, it’s a protocol that works on the street and in clinic, with clear timing, meds, and contingencies that honor how people actually live.

If this helped you rethink induction in the fentanyl era, follow the show, share it with a colleague, and leave a quick review so more clinicians and families can find it. Treating addiction saves lives—let’s make the first step easier.

To contact Dr. Grover: [email protected]

A lot of people think addiction begins with a bad decision. We start earlier—at the moments when consent was stolen, trust collapsed, and silence felt safer than speaking. Carly sits down with us to map the real terrain: childhood sexual assault, a near-rape behind a high school bonfire, military harassment that exploited rank, and the long slide from alcohol to meth, from oxy to heroin. The story is raw and specific, and it asks a bigger question we should all be wrestling with: what if addiction isn’t the disease, but the way we cope with the ones we don’t treat?

We walk through the culture of the OxyContin generation, the false safety of pills, and why heroin often follows when access dries up. Carly explains how meth’s euphoria and laser focus quieted a mind on fire, and why boundaries—not willpower—became the non‑negotiable tools of her recovery. We dig into homelessness, the dangerous logic of abusive relationships, and a nuanced view of sex work as both survival and, at times, chosen agency. It’s complicated on purpose; real lives are.

What stands out most is the timeline. She got clean from heroin years before she learned relationship sobriety. That difference matters to anyone supporting survivors or working in addiction medicine: cravings don’t exist in a vacuum, and trauma doesn’t disappear at discharge. We talk about “playing the tape forward,” spotting red flags early, and building safety that might look extreme to outsiders but keeps a survivor alive and growing.

If you care about trauma-informed recovery, sexual assault, military harassment, homelessness, sex work, and the real mechanics of healing, you’ll find honesty here you can use. Listen, share with someone who needs to hear it, and leave a review so others can find the show. Your feedback helps us keep having the hard conversations that save lives.

To contact Dr. Grover: [email protected]

I sat down with a room full of high school seniors to talk to them about party culture in college. 

College freedom can be thrilling—and unforgiving. As an ER physician turned addiction specialist, I pull back the curtain on campus party culture with real stories, clear limits, and life-saving tactics to be used the first weekend of college. From Narcan basics and Good Samaritan protections to the truth about binge drinking, this conversation lays out what actually keeps college students safe when nights get loud and fast.

We start with the numbers: what high-risk drinking is, why “I can hold my liquor” isn’t a flex but a warning sign, and how body size and sex change BAC more than most people realize. Then we walk through the pressure cookers—Greek life hazing, pre-gaming, shotgunning beers, beer bongs, keg stands, and jungle juice—explaining why compressing 10 drinks into an hour is the exact scenario that leads to blackouts, injuries, and assaults. I teach simple, effective steps: eat first, alternate drinks with water, stick with sealed beverages you open yourself, and never leave your cup behind. We talk candidly about consent, spiked drinks, and why half of campus sexual assaults involve alcohol.

The episode also tackles cannabis in 2026: today’s THC is a different drug than what parents remember. We unpack potency, “greening out,” rising rates of cannabis-induced paranoia and psychosis, and how frequent use intersects with attention, grades, and graduation. Along the way, I share ER-tested guidance for handling alcohol poisoning—when to observe, when to call 911, and how to position someone safely—as well as how to spot early signs of alcohol addiction in college students and get help through campus health services.

If you’re a senior heading to college, a parent, or a mentor, this is a clear-eyed playbook for staying safe without sitting out. Subscribe, share this with a student you care about, and leave a quick review—it helps more people find practical, judgment-free advice when they need it most.

To contact Dr. Grover: [email protected]

Hypnosis and moderation rarely share the same sentence—until you understand how your brain decides to drink. We sit down with Australian clinical hypnotherapist Georgia Foster to unpack a practical, science‑aligned approach to reducing alcohol that starts by changing state, not shaming behavior. Georgia explains why the amygdala’s fear and urgency often override the best intentions, how the inner critic fuels that cycle, and what it takes to bring the prefrontal cortex—the calm, planning center—back online when it matters.

You’ll hear how two common patterns show up in overdrinking. The perfectionist white‑knuckles through the week, then binges on relief because there are no references for slow, present drinking. The pleaser says yes to keep the peace, struggling to stay alcohol‑free in social settings. Georgia shows how hypnosis creates new “future references” by rehearsing success in the alpha‑theta window, the natural state between wake and sleep. By pairing imagined events with emotions like confidence, ease, and clarity, the brain encodes a different blueprint—so at a wedding, work dinner, or solo evening at home, choice feels obvious and safe.

We also dig into mindless home routines, the difference between emotional and habitual drinking, simple tactics like “drink one, water one,” and why many people discover they don’t even like what they were pouring once the inner critic quiets down. Georgia shares who responds fastest to hypnotherapy, when to seek additional support, and why building self‑esteem is central to long‑term change. Along the way, we talk about privacy, digital programs, and her goal to help one million people drink less by replacing shame with skill.

If this conversation resonates, follow the show, share it with a friend who could use a gentler path, and leave a quick review—your words help others find evidence‑informed help and start their own change.

To learn more about Georgia's work: https://shop.georgiafoster.com/

To contact Dr. Grover: [email protected]